{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:33:13Z","timestamp":1760866393896,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jceh.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T04:13:02Z","timestamp":1654920782000},"page":"1580-1590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Post-COVID-19 Cholestasis: A Case Series and Review of Literature"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-1675","authenticated-orcid":false,"given":"Anand V.","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7032-9202","authenticated-orcid":false,"given":"Amit","family":"Khelgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Sekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-392X","authenticated-orcid":false,"given":"Raghuram","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowmya","family":"Tirumalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baqar A.","family":"Gora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Somireddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jignesh","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balachandran","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duvvur N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaraja P.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.06.004_bib1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jmv.26368","article-title":"Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation","volume":"93","author":"Halpin","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jceh.2022.06.004_bib2","first-page":"2021","article-title":"Post-COVID-19 symptoms are not uncommon among recovered patients-a cross-sectional online survey among the Indian population","author":"Rao","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jceh.2022.06.004_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.15916","article-title":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19","volume":"52","author":"Kulkarni","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.06.004_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101025","article-title":"Impact of COVID-19 on liver transplant recipients-a systematic review and meta-analysis","volume":"38","author":"Kulkarni","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jceh.2022.06.004_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.14309\/ajg.0000000000000914","article-title":"Elevated liver chemistries in COVID-19-is it not a concern?","volume":"116","author":"Kumar","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.004_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jceh.2020.05.006","article-title":"Pathogenesis of liver injury in coronavirus disease 2019","volume":"10","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.06.004_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/joim.13292","article-title":"Cholestatic liver injury in COVID-19 is a rare and distinct entity and is associated with increased mortality","volume":"290","author":"Da","year":"2021","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jceh.2022.06.004_bib8","first-page":"e11","article-title":"Patterns and prediction of liver injury with persistent cholestasis in survivors of severe SARS-CoV-2 infection","volume":"82","author":"Nayagam","year":"2021","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jceh.2022.06.004_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.14309\/ajg.0000000000001154","article-title":"Post-COVID-19 cholangiopathy: a novel entity","volume":"116","author":"Roth","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.004_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.transproceed.2021.03.007","article-title":"Post-COVID-19 cholangiopathy-a new indication for liver transplantation: a case report","volume":"53","author":"Durazo","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.06.004_bib11","article-title":"Clinical outcomes in vaccinated individuals hospitalized with delta variant of SARS-CoV-2","author":"Jagadeesh Kumar","year":"2021","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.jceh.2022.06.004_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/hep4.1853","article-title":"SARS-CoV-2 infections among patients with liver disease and liver transplantation who received COVID-19 vaccination","volume":"6","author":"Moon","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.06.004_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.06.004_bib14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.31751","article-title":"American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease. Updated: v10.0 released november 2, 2021","volume":"74","author":"Fix","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.06.004_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.14309\/ajg.0000000000001264","article-title":"Cholangiopathy after severe COVID-19: clinical features and prognostic implications","volume":"116","author":"Faruqui","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237984","article-title":"Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection","volume":"13","author":"Edwards","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jceh.2022.06.004_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jhep.2021.02.007","article-title":"Intravenous ketamine and progressive cholangiopathy in COVID-19 patients","volume":"74","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.jceh.2022.06.004_bib18","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/liv.14971","article-title":"Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19","volume":"41","author":"B\u00fctikofer","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.06.004_bib19","first-page":"400","article-title":"Vasculopathy-related cutaneous lesions and intrahepatic cholestasis as synchronous manifestations in a COVID-19 patient; a case report","volume":"13","author":"Sadeghi","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.jceh.2022.06.004_bib20","first-page":"276","article-title":"Favipiravir-induced liver injury in patients with coronavirus disease 2019","volume":"9","author":"Kumar","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2022.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97160-3","article-title":"Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics","volume":"11","author":"Ambrus","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.06.004_bib22","doi-asserted-by":"crossref","first-page":"S1267","DOI":"10.14309\/01.ajg.0000711576.79113.c0","article-title":"S2382 COVID-19 and cholestasis: potential role of interleukin-6","volume":"115","author":"Satiya","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.004_bib23","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/ajt.16509","article-title":"Early liver transplantation after COVID-19 infection: the first report","volume":"21","author":"Kulkarni","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.06.004_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jceh.2020.12.007","article-title":"Severe acute respiratory syndrome coronavirus 2-related acute-on-chronic liver failure","volume":"11","author":"Kumar","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.06.004_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jceh.2021.09.007","article-title":"COVID-19 masquerading as autoimmune hepatitis (AIH) flare-the first report","volume":"12","author":"Kulkarni","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.06.004_bib26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12072-021-10181-y","article-title":"Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study","volume":"15","author":"Satapathy","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2022.06.004_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.jceh.2022.06.004_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.transci.2013.04.009","article-title":"Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: a single center experience","volume":"48","author":"Keklik","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jceh.2022.06.004_bib29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1665-2681(19)31448-6","article-title":"Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters","volume":"11","author":"Krawczyk","year":"2012","journal-title":"Ann Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:29Z","timestamp":1760854109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0973688322001372"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.06.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-COVID-19 Cholestasis: A Case Series and Review of Literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}